中华骨质疏松和骨矿盐疾病杂志Issue(4)：369-373,5.DOI:10.3969/j.issn.1674-2591.2014.04.013
男性骨质疏松症药物治疗
The treatment of male osteoporosis
马豆豆 1范志宏 2李梅1
作者信息
- 1. 100730 北京，中国医学科学院 北京协和医学院 北京协和医院内分泌科，卫生部内分泌重点实验室
- 2. 030001 太原，山西医科大学第二医院内分泌科
- 折叠
摘要
Abstract
Male osteoporosis is a common but under-recognized disease with growing prevalence .Approved ther-apies to male osteoporosis include the bisphosphonates , parathyroid hormone , androgen and the monoclonal antibody against receptor activator of nuclear factor-kappa B ligand ( RANKL) .A good deal of new drugs are expected to improve the bone strength and the life quality of male osteoporosis .We review the treatment of male osteoporosis in order to im-prove the understanding of this disease .关键词
男性骨质疏松症/治疗Key words
male osteoporosis/treatment分类
医药卫生引用本文复制引用
马豆豆,范志宏,李梅..男性骨质疏松症药物治疗[J].中华骨质疏松和骨矿盐疾病杂志,2014,(4):369-373,5.
